Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 07 - 06 tags : Collaboration save search
OncoSec Enters into a Collaboration Agreement with Merck for a Pivotal Global Phase 3 Study, KEYNOTE-C87, of TAVO™ Combined with KEYTRUDA® for Late-Stage Metastatic Melanoma
Published: 2021-07-06 (Crawled : 20:00) - prnewswire.com
ONCS | $0.2772 25.59% 52M
|
Health Services
|
| O: 20.43%
H: 26.49%
C: 1.19%
collaboration phase 3 keytruda
AT&T and Google Cloud Expand 5G and Edge Collaboration to Deliver Next-Generation Business Outcomes
Published: 2021-07-06 (Crawled : 15:00) - prnewswire.com
T | $16.5 1.17% -0.21% 48M
|
Communications
|
| O: 0.55%
H: 0.17%
C: -0.89%
5g collaboration liver
Agenus Closes $200M Upfront BMS Collaboration and Announces FDA Acceptance of IND for Partnered Anti-TIGIT Bispecific Antibody, AGEN1777
Published: 2021-07-06 (Crawled : 13:00) - globenewswire.com
AGEN A | $6.44 11.61% 10.4% 1.7M
|
Health Technology
|
| O: 1.17%
H: 0.35%
C: -4.1%
fda fda acceptance collaboration antibody
Arbutus Biopharma and Vaccitech Announce Clinical Trial Collaboration Agreement to Evaluate RNAi Therapeutic, AB-729, in Combination with Immunotherapeutic, VTP-300, in Subjects with Chronic Hepatitis B Virus Infection
Published: 2021-07-06 (Crawled : 12:00) - biospace.com/
ABUS | $2.74 3.79% 3.65% 1.1M
|
Health Technology
|
| O: -3.87%
H: 0.0%
C: -1.68%
hepatitis biopharma collaboration trial injection infections chronic hepatitis b
Kura Oncology Announces Clinical Collaboration to Evaluate Tipifarnib in Combination with Alpelisib in Head and Neck Squamous Cell Carcinoma
Published: 2021-07-06 (Crawled : 12:00) - globenewswire.com
KURA | News | $18.74 3.02% 2.93% 1M
|
Health Technology
|
| O: -2.7%
H: 0.14%
C: -6.02%
collaboration cell carcinoma
Cybin Enters into Collaboration Agreement with Greenbrook TMS to Establish Mental Health Centers of Excellence
Published: 2021-07-06 (Crawled : 12:00) - biospace.com/
GBNH | $0.121 -4.88% 6M
|
Manufacturing
|
| O: -1.31%
H: 8.06%
C: 6.31%
collaboration health
GE Healthcare and SOPHiA GENETICS to collaborate to match treatments to multimodal patient data and cancer type
Published: 2021-07-06 (Crawled : 11:00) - prnewswire.com
GE | News | $162.62 8.28% 0.22% 19M
|
Electronic Technology
|
| O: -1.78%
H: 0.3%
C: -2.71%
treatment genetic cancer oda collaboration
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.